243
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Timelines to Cervical Cancer Diagnosis and Treatment at a Tertiary Hospital in Botswana

, , &
Pages 385-393 | Published online: 23 Apr 2021

References

  • Marc A, Elisabete W, Laia B, et al. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lacent Global Health. 2020;8(2):E191–E203.
  • World Health Organization. Comprehensive Cervical Cancer Control: A Guide to Essential Practice. Second ed. 2014; 49–54.
  • Mingo AM, Panozzo CA, DiAngi YT, et al. Cervical cancer awareness and screening in Botswana. Int J Gynecol Cancer. 2012;22(4):638. doi:10.1097/IGC.0b013e318249470a
  • Nassali MN, Tadele MB, Robert MN, Jamieson M, Iwuh E, Katse E. Predictors of locally advanced disease at presentation and clinical outcomes among cervical cancer patients admitted at a tertiary hospital in Botswana. Int J Gynecol Cancer. 2018;28(6):1218–1225. doi:10.1097/IGC.0000000000001284
  • Grover S, Chiyapo S, Puri P, et al. Multidisciplinary gynecologic oncology clinic in Botswana: a model for multidisciplinary oncology care in low- and middle-income settings. J Glob Oncol. 2017;3(5):666–670. doi:10.1200/JGO.2016.006353
  • Grover S, Raesima M, Bvochora-Nsingo M, et al. Cervical cancer in Botswana: current state and future steps for screening and treatment programs. Front Oncol. 2015;5:1–5. doi:10.3389/fonc.2015.00239
  • Rudd P, Gorman D, Meja S, et al. Cervical cancer in southern Malawi: a prospective analysis of presentation, management, and outcomes. Malawi Med J. 2017;29(2):124–129. doi:10.4314/mmj.v29i2.9
  • Lim AWW, Forbes LJL, Rosenthal AN, et al. Measuring the nature and duration of symptoms of cervical cancer in young women: developing an interview-based approach. BMC Women's Health. 2013;13:45. doi:10.1186/1472-6874-13-45
  • Mwaka AD, Okello ES, Wabinga H, Walter FM. Symptomatic presentation with cervical cancer in Uganda: a qualitative study assessing the pathways to diagnosis in a low-income country. BMC Women's Health. 2015;15:15. doi:10.1186/s12905-015-0167-4
  • Statistics Botswana. Health Statistics Brief 2007–2015. Gaborone: Statistics Botswana; 2017.
  • Lohlun K, Kotzen J, Lakier R. A prospective study on the impact of waiting times for radiotherapy for cervical cancer at Charlotte Maxeke Johannesburg Academic Hospital, South Africa. S Afr J Obstet Gynaecol. 2015;21:6–9. doi:10.7196/sajog.985
  • Powis S. Clinically-led Review of NHS Access Standards. 2019.
  • World Health Organization. Framework for Strengthening and Scaling-Up Services for the Management of Invasive Cervical Cancer. Geneva: World Health Organization; 2020.
  • Di Girolamo C, Walters S, Gildea C, et al. Can we assess cancer waiting time targets with cancer survival? A population-based study of individually linked data from the National Cancer Waiting Times monitoring dataset in England, 2009–2013. PLoS One. 2018;13(8):e0201288–e0201288. doi:10.1371/journal.pone.0201288
  • Song H, Fang F, Valdimarsdóttir U, et al. Waiting time for cancer treatment and mental health among patients with newly diagnosed esophageal or gastric cancer: a nationwide cohort study. BMC Cancer. 2017;17(1):2. doi:10.1186/s12885-016-3013-7
  • Royal College of Pathologists. Key Performance Indicators in Pathology. Recommendations from the Royal College of Pathologists. 2013.
  • Singh H, Vij MS. Eight recommendations for policies for communicating abnormal test results. Joint Commission J Qual Patient Saf. 2010;36(5):226–AP222.
  • Wu SG, Zhang WW, He ZY, Sun JY, Wang Y, Zhou J. Comparison of survival outcomes between radical hysterectomy and definitive radiochemotherapy in stage IB1 and IIA1 cervical cancer. Cancer Manag Res. 2017;9:813–819. doi:10.2147/CMAR.S145926